1 result for day: 17/09/2017Not what you're looking for? Search Again
Could ketamine help manage pain in patients with post-treatment Lyme disease syndrome?
Lyme disease patients oftentimes suffer from ongoing illness following treatment. A study by Bechtold and colleagues found that 31% of patients remained in significant pain for months after a three-week course of doxycycline to treat an EM rash. [1] Six percent of their patients developed post-treatment Lyme disease syndrome (PTLDS). Now, a new case report examines the effectiveness of intravenous ketamine on managing pain in a patient with post-treatment Lyme disease syndrome.
